Bremer Bank National Association’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-49,479
Closed -$4.26M 181
2024
Q4
$4.26M Buy
49,479
+924
+2% +$99.9K 0.84% 43
2024
Q3
$5.78M Sell
48,555
-2,257
-4% -$301K 1.09% 30
2024
Q2
$7.25M Sell
50,812
-1,098
-2% -$145K 1.42% 19
2024
Q1
$6.67M Buy
+51,910
New +$6.18M 1.23% 20
2019
Q2
Sell
-1,680
Closed -$41K 515
2019
Q1
$41K Buy
+1,680
New +$41.3K 0.01% 487

Other funds holding NVO

Bremer Bank National Association's NVO Position: Q1 2025 in Review

Bremer Bank National Association sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 49,479 shares — an estimated $4.26M sold.

Bremer Bank National Association first reported a position in NVO in Q1 2019 and held it in 5 quarters. The position peaked at $7.25M in Q2 2024. 1,529 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Bremer Bank National Association reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Bremer Bank National Association sold 49,479 Novo Nordisk shares in Q1 2025, an estimated $4.26M.
  • Bremer Bank National Association first reported a position in Novo Nordisk in Q1 2019 and held it in 5 quarters.
  • Bremer Bank National Association's Novo Nordisk position peaked at $7.25M in Q2 2024.
  • 1,529 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Bremer Bank National Association's 13F filing for Q1 2025, filed 10 Apr 2025.